Arch Therapeutics, Inc.
ARTH · OTC
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
|---|---|---|---|---|
| Market Cap | $3,996 | $4,606 | $28,600 | $6,515,988 |
| - Cash | $223 | $747 | $2,267 | $959 |
| + Debt | $5,628 | $3,362 | $1,600 | $726 |
| Enterprise Value | $9,401 | $7,222 | $27,934 | $6,515,755 |
| Revenue | $76 | $16 | $12 | $0 |
| % Growth | 383.8% | 35.3% | – | – |
| Gross Profit | -$2 | -$36 | -$15 | -$7 |
| % Margin | -3.2% | -229% | -127.3% | – |
| EBITDA | -$3,884 | -$4,706 | -$6,087 | -$5,345 |
| % Margin | -5,129.6% | -30,064% | -52,636.1% | – |
| Net Income | -$6,983 | -$4,276 | -$6,569 | -$4,012 |
| % Margin | -9,221.4% | -27,318.3% | -56,802.8% | – |
| EPS Diluted | -2.27 | -3.56 | -5.97 | -4.27 |
| % Growth | 36.2% | 40.4% | -39.8% | – |
| Operating Cash Flow | -$3,374 | -$4,456 | -$5,959 | -$5,045 |
| Capital Expenditures | -$5 | $0 | -$3 | -$2 |
| Free Cash Flow | -$3,379 | -$4,456 | -$5,962 | -$5,047 |